Cart
sales@molnova.com
CBS9106
CAS No. 1076235-04-5
CBS9106( —— )
Catalog No. M33306 CAS No. 1076235-04-5
CBS9106 (SL-801) is a reversible oral CRM1 inhibitor with CRM1 degrading and antitumor activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 400 | Get Quote |
|
| 5MG | 613 | Get Quote |
|
| 10MG | 847 | Get Quote |
|
| 25MG | 1270 | Get Quote |
|
| 50MG | 1730 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCBS9106
-
NoteResearch use only, not for human use.
-
Brief DescriptionCBS9106 (SL-801) is a reversible oral CRM1 inhibitor with CRM1 degrading and antitumor activity.
-
DescriptionCBS9106 (SL-801) is a reversible oral CRM1 inhibitor with CRM1 degrading and antitumor activity.CBS9106 inhibits CRM1-dependent nuclear export and reduces CRM1 protein levels.CBS9106 inhibits tumor growth and prolongs the survival of mice bearing tumor xenografts.CBS9106 is an inhibitor of CRM1-dependent nuclear export and reduces CRM1 protein levels.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetCRM1
-
RecptorCRM1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1076235-04-5
-
Formula Weight419.83
-
Molecular FormulaC18H21ClF3N3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C(=C(C(=O)N1NC2=NC(Cl)=C(C=C2)C(F)(F)F)COCCC(C)(C)C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
KPT276
KPT-276 is an orally bioavailable selective inhibitor of nuclear export (SINE) that irreversibly bind to CRM1 and block the function of CRM1.
-
Leptomycin B
Leptomycin B is a potent inhibitor of the nuclear export of proteins and is a potent antifungal antibiotic blocking the eukaryotic cell cycle. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue.
-
CBS9106
CBS9106 (SL-801) is a reversible oral CRM1 inhibitor with CRM1 degrading and antitumor activity.
